Kanagawa, Japan

Hitoshi Yamada

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Meiji Seika Kaisha, Ltd.. Active years: 1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hitoshi Yamada. Retrieved from https://idiyas.com/inventor/hitoshi-yamada-fjkufrub

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1985

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hitoshi Yamada: Innovator in Pharmaceutical Chemistry

Introduction

Hitoshi Yamada is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. His work has implications for the development of new medications and therapeutic methods.

Latest Patents

Hitoshi Yamada holds a patent for a compound known as Sodium - Sodium 7.beta.-(2D-2-amino-2-carboxyethylthioacetamido)-7.alpha.-methoxy-3-(1-methyl-1H-tetrazol-5-yl)thiomethyl-3-cephem-4-carboxylate heptahydrate. This patent outlines a method for obtaining this compound from the corresponding carboxylate, showcasing his expertise in chemical synthesis.

Career Highlights

Yamada is associated with Meiji Seika Kaisha, Ltd., a prominent company in the pharmaceutical industry. His role at the company has allowed him to focus on research and development, contributing to advancements in drug formulation and delivery.

Collaborations

Throughout his career, Hitoshi Yamada has collaborated with esteemed colleagues, including Ken Nishihata and Katsuharu Iinuma. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Hitoshi Yamada's contributions to pharmaceutical chemistry through his patent and collaborative efforts highlight his role as an influential inventor. His work continues to impact the field and pave the way for future innovations in medication development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…